Resmed Inc. (RMD) Review – Making Smarter Decisions

Resmed Inc. (NYSE: RMD) is 6.82% higher on its value in year-to-date trading and has touched a low of $132.24 and a high of $243.52 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The RMD stock was last observed hovering at around $186.59 in the last trading session, with the day’s loss setting it -2.84%.

Currently trading at $183.75, the stock is 0.93% and 6.08% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.89 million and changing -1.52% at the moment leaves the stock 0.88% off its SMA200. RMD registered -18.13% loss for a year compared to 6-month gain of 3.86%. The firm has a 50-day simple moving average (SMA 50) of $6.26 and a 200-day simple moving average (SMA200) of $19.73.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.
Sponsored

The stock witnessed a 3.33% loss in the last 1 month and extending the period to 3 months gives it a 22.29%, and is -5.12% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 2.11% over the week and 2.62% over the month.

Resmed Inc. (RMD) has around 10140 employees, a market worth around $27.03B and $4.50B in sales. Current P/E ratio is 30.44 and Fwd P/E is 22.36. Profit margin for the company is 19.77%. Distance from 52-week low is 38.95% and -24.54% from its 52-week high. The company has generated returns on investments over the last 12 months (15.25%).

Resmed Inc. quarterly earnings per share for the current quarter are estimated at $1.9 with sales reaching $1.17B over the same period.The EPS is expected to grow by 15.05% this year, but quarterly earnings will post 9.70% year-over-year.

1,028 institutions hold shares in Resmed Inc. (RMD), with institutional investors hold 62.39% of the company’s shares. The shares outstanding are 147.06M, and float is at 145.90M with Short Float at 4.04%. Institutions hold 61.87% of the Float.

The top institutional shareholder in the company is Vanguard Group Inc with over 17.58 million shares valued at $3.84 billion. The investor’s holdings represent 11.95% of the RMD Shares outstanding. As of Jun 29, 2023, the second largest holder is Blackrock Inc. with 12.24 million shares valued at $2.67 billion to account for 8.32% of the shares outstanding. The other top investors are State Street Corporation which holds 6.39 million shares representing 4.34% and valued at over $1.4 billion, while FMR, LLC holds 4.14% of the shares totaling 6.09 million with a market value of $1.33 billion.

Resmed Inc. (RMD) Insider Activity

A total of 48 insider transactions have happened at Resmed Inc. (RMD) in the last six months, with sales accounting for 28 and purchases happening 20 times. The most recent transaction is an insider sale by Sandercock Brett, the company’s Chief Financial Officer. SEC filings show that Sandercock Brett sold 3,000 shares of the company’s common stock on Nov 27 at a price of $152.62 per share for a total of $0.46 million. Following the sale, the insider now owns 92962.0 shares.

Resmed Inc. disclosed in a document filed with the SEC on Nov 15 that Farrell Michael J. (Chief Executive Officer) sold a total of 5,678 shares of the company’s common stock. The trade occurred on Nov 15 and was made at $152.04 per share for $0.86 million. Following the transaction, the insider now directly holds 0.44 million shares of the RMD stock.

Still, SEC filings show that on Nov 01, Rider Michael J (Global General Counsel) disposed off 25 shares at an average price of $143.42 for $3585.0. The insider now directly holds 7,358 shares of Resmed Inc. (RMD).

Resmed Inc. (RMD): Who are the competitors?

One of the company’s main competitors (and peers) include Five Point Holdings LLC Cl A (FPH) that is trading 42.80% up over the past 12 months.Dentsply Sirona Inc. (XRAY) lies in the list of competitors of the Resmed Inc. and is -7.61% lower over the same period from RMD